Nance, Danielle <br/><br/>
Switching haemophilia products and inhibitor risk: a United States' perspective.  [electronic resource] 

 -  European journal of haematology  Apr 2015 
 - 283 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/ejh.12441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Substitution<br/>Factor IX--antagonists & inhibitors<br/>Factor VIII--antagonists & inhibitors<br/>Hemophilia A--drug therapy<br/>Hemophilia B--drug therapy<br/>Humans<br/>Isoantibodies--immunology<br/>Recombinant Proteins--immunology<br/>Risk